Type 1 diabetes mellitus (T1DM) is an autoimmune disorder characterized by absolute insulin deficiency, necessitating lifelong exogenous insulin therapy. Pharmacological management aims to replicate physiological insulin secretion as closely as possible while minimizing hypoglycemia, glycemic variability, and long-term microvascular and macrovascul
Vildagliptin in Reducing Risk of Post-partum Diabetes
2386 Reached7 Comments4 Likes
Link between PCOS, Obesity and Diabetes
479 Reached2 Likes
Risk Factors Associated Glycemia in LBW Infants
2793 Reached2 Comments1 Likes
Autoimmune Hepatitis in Girl with T1DM
1156 Reached2 Comments4 Likes
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes